Your activity: 42 p.v.
your limit has been reached. plz Donate us to allow your ip full access, Email: sshnevis@outlook.com

Prevention of prosthetic joint and other types of orthopedic hardware infection

Prevention of prosthetic joint and other types of orthopedic hardware infection
Authors:
Elie Berbari, MD, FIDSA
Larry M Baddour, MD, FIDSA, FAHA
Section Editor:
Denis Spelman, MBBS, FRACP, FRCPA, MPH
Deputy Editor:
Keri K Hall, MD, MS
Literature review current through: Dec 2022. | This topic last updated: Jun 20, 2022.

INTRODUCTION — Effective management of prosthetic joint infection (PJI) and other types of orthopedic hardware infection requires surgery and prolonged antimicrobial therapy; treatment failure is common. Given the challenges associated with treating these infections, prevention of infection is clearly desirable.

Most literature pertaining to the prevention of orthopedic hardware infection is derived from studies on patients with joint arthroplasties. Data regarding other types of orthopedic hardware are limited; however, in general, similar principles of prevention may apply.

Guidelines addressing prevention strategies include the United States Centers for Disease Control and Prevention guideline for prevention of surgical site infection [1], the National Surgical Infection Prevention Project [2,3], guidelines from the Medical Letter (table 1) [4], guidelines from the American Society of Health-System Pharmacists [5], and an Advisory Statement from the American Academy of Orthopaedic Surgeons [6].

Issues related to the prevention of orthopedic hardware infection will be reviewed here. General principles for prevention of surgical site infection are discussed separately. (See "Overview of control measures for prevention of surgical site infection in adults".)

The epidemiology, clinical manifestations, diagnosis, and treatment of orthopedic hardware infections are discussed separately. (See "Prosthetic joint infection: Epidemiology, microbiology, clinical manifestations, and diagnosis" and "Prosthetic joint infection: Treatment".)

PRIOR TO HARDWARE PLACEMENT

Staphylococcus aureus decolonization — Issues related to Staphylococcus aureus decolonization prior to orthopedic surgery are discussed further separately. (See "Overview of control measures for prevention of surgical site infection in adults", section on 'S. aureus decolonization'.)

Other preventive measures — Other preventive measures prior to hardware placement include:

There is no role for routine diagnosis or treatment of asymptomatic bacteriuria among patients undergoing joint arthroplasty or other orthopedic hardware placement [7-10]. This issue is discussed further separately. (See "Asymptomatic bacteriuria in adults", section on 'Joint arthroplasty'.)

A dental evaluation should be undertaken to assess and manage for the presence of gingivitis, occult dental abscess, or decay.

Patients should be instructed not to shave their lower limbs prior to knee or hip replacement. If needed, hair removal may be performed with clippers immediately prior to surgery [11]. (See "Overview of control measures for prevention of surgical site infection in adults", section on 'Hair removal'.)

When feasible, certain immunosuppressive therapy should be tapered to the lowest dose possible or discontinued. Tumor necrosis factor-alpha blockers should be discontinued as early as possible prior to hardware placement if feasible [12]. In the absence of relevant comorbid conditions and/or risk factors associated with infection, continuing low doses of methotrexate or steroids may be acceptable during the perioperative period in patients with rheumatoid arthritis [12].

Other issues related to prevention of surgical infection are discussed separately. (See "Overview of control measures for prevention of surgical site infection in adults".)

DURING HARDWARE PLACEMENT

Surgical approach — Surgical issues related to hip and knee arthroplasty are discussed separately. (See "Total hip arthroplasty" and "Total knee arthroplasty".)

Antimicrobial prophylaxis — Orthopedic hardware infections are commonly due to S. aureus or coagulase-negative staphylococci. Surgical antimicrobial prophylaxis with cefazolin is warranted for patients undergoing joint replacement or placement of other orthopedic hardware (ie, plates and screws); acceptable alternatives to cefazolin (particularly for patients with a history of type I penicillin or other beta-lactam allergy) include vancomycin or clindamycin (table 1) [5,13].

It is advisable to refer patients with history of beta-lactam allergy for allergy evaluation prior to orthopedic surgery given data suggesting alternative antibiotics are inferior to cefazolin for prevention of hardware infection [14-17]; in such cases many patients are skin-test negative and tolerate beta-lactam administration. (See "An approach to the patient with drug allergy".)

Most studies that have evaluated intravenous antimicrobial prophylaxis in orthopedic hardware placement have been conducted in patients undergoing total hip or knee arthroplasty [3,4,6,13,18-20]. There is a lack of efficacy data involving elbow, shoulder, and ankle arthroplasty; however, the same principles of antimicrobial prophylaxis may be applied [5].

In general, the entire dose of antibiotic should be infused prior to tourniquet inflation. Administering part of the dose just prior to tourniquet release may be acceptable in some circumstances [21], particularly for patients undergoing replacement arthroplasty for management of preexisting infection of the prosthesis [22].

Antibiotic prophylaxis should not be delayed in patients undergoing revision arthroplasty for suspected or confirmed prosthetic joint infection (PJI) in an effort to optimize culture sensitivity [23].

For clean and clean-contaminated procedures, readministration of antimicrobial prophylaxis in the operating room following closure of the surgical incision is not warranted, even in the presence of a drain [1,3,5,24-26].

General principles related to antimicrobial prophylaxis for prevention of surgical site infection are discussed further separately. (See "Antimicrobial prophylaxis for prevention of surgical site infection in adults".)

Local antibiotic delivery — Forms of local antibiotic delivery include antimicrobial-laden fixation cement and antimicrobial-laden sponges.

The use of low-dose antimicrobial-laden fixation cement for prevention of infection in primary cemented hip and knee arthroplasty (in conjunction with intravenous antimicrobial prophylaxis) is common practice [27-30]. The optimal use of this strategy and the potential for the development of resistance has not been fully assessed [31-34]; it may be appropriate in selected patients at increased risk for infection [35,36]. Issues related to use of antibiotic-laden cement for treatment of PJI are discussed separately. (See "Prosthetic joint infection: Treatment", section on 'Resection arthroplasty with reimplantation'.)

The use of gentamicin-containing collagen sponges has not been shown to reduce the incidence of surgical site infection after joint arthroplasty [37]. This issue is discussed further separately. (See "Overview of control measures for prevention of surgical site infection in adults", section on 'Topical and local antibiotic delivery'.)

FOLLOWING HARDWARE PLACEMENT — Signs or symptoms of wound infection following hardware replacement should be addressed promptly and aggressively with local wound measures and antibiotic therapy directed against the likely pathogens.

There is no evidence to suggest that patients with orthopedic hardware undergoing procedures should receive antibiotic prophylaxis in the absence of other indications, such as heart valve disease requiring endocarditis prophylaxis or a surgical procedure for which antibiotics are given to prevent a surgical site infection.

Dental procedures — Based on available data and consistent with expert guidelines from both the American Dental Association (ADA) and the American Academy of Orthopedic Surgeons (AAOS), we advise against the routine use of antibiotic prophylaxis in patients with prosthetic joints undergoing dental procedures [38,39]. Dental procedures are not associated with an increased risk of orthopedic hardware infection, and use of routine antibiotic prophylaxis prior to dental procedures, including invasive procedures, does not alter the risk of subsequent orthopedic hardware infection [39-46]. We recommend maintaining good oral hygiene so that bacteremia due to oral flora is less likely to occur during routine daily oral care [47]. In addition, we recommend that dental infections be promptly treated. Treatment of dental infections is discussed in detail elsewhere.

In a hospital-based study of 339 patients with PJI and 339 matched-controls with a prosthetic joint but no infection, PJI was not associated with prior low-risk or high-risk dental procedures [41]. Review of dental records revealed that antibiotics prior to dental procedures did not alter the subsequent risk of PJI. Similarly, a nationwide observational study from England, where antibiotic prophylaxis for dental procedures is not used, found no temporal association between invasive dental procedures and late PJI among over 9000 individuals with PJI [46].

Urologic procedures — In general, antimicrobial prophylaxis for prevention of orthopedic hardware infection is not warranted for patients with orthopedic hardware undergoing cystoscopy [48]. Antimicrobial prophylaxis may be appropriate in selected patients, especially those with immunosuppression undergoing a procedure with increased risk of bacteremia, such as lithotripsy or surgery involving bowel segments [49].

Gastrointestinal procedures — In general, antimicrobial prophylaxis for prevention of orthopedic hardware infection is not warranted for patients with orthopedic hardware undergoing gastrointestinal endoscopies [50].

SOCIETY GUIDELINE LINKS — Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See "Society guideline links: Osteomyelitis and prosthetic joint infection in adults".)

SUMMARY AND RECOMMENDATIONS

Antibiotic prophylaxis during orthopedic surgery – Surgical antimicrobial prophylaxis is warranted for all patients undergoing orthopedic hardware placement; regimens are summarized in the table (table 1). (See 'Antimicrobial prophylaxis' above.)

No role for antibiotic prophylaxis prior to dental procedures – Based on available data and consistent with expert guidelines from both the American Dental Association (ADA) and the American Academy of Orthopedic Surgeons (AAOS), we advise against the routine use of antibiotic prophylaxis in patients with prosthetic joints undergoing dental procedures (Grade 1B). Patients who have another indication for pre-dental-procedure prophylaxis (such as heart valve disease requiring endocarditis prophylaxis or a surgical procedure for which antibiotics are given to prevent a surgical site infection) should receive antibiotics. (See 'Dental procedures' above.)

Antibiotic prophylaxis prior to other procedures – In general, antimicrobial prophylaxis for prevention of orthopedic infection is not warranted for patients with prosthetic joints undergoing urologic or gastrointestinal procedures. (See 'Following hardware placement' above.)

  1. Berríos-Torres SI, Umscheid CA, Bratzler DW, et al. Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, 2017. JAMA Surg 2017; 152:784.
  2. Bratzler DW, Houck PM, Surgical Infection Prevention Guidelines Writers Workgroup, et al. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis 2004; 38:1706.
  3. Bratzler DW, Hunt DR. The surgical infection prevention and surgical care improvement projects: national initiatives to improve outcomes for patients having surgery. Clin Infect Dis 2006; 43:322.
  4. Antimicrobial prophylaxis for surgery. Treat Guidel Med Lett 2012; 10:73.
  5. Bratzler DW, Dellinger EP, Olsen KM, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm 2013; 70:195.
  6. American Academy of Orthopedic Surgeons. Recommendations for the Use of Intravenous Antibiotic Prophylaxis in Primary Total Joint Arthroplasty. https://www.aaos.org/globalassets/about/bylaws-library/information-statements/1027-recommendations-for-the-use-of-intravenous-antibiotic-prophylaxis-in-primary-total-joint-arthroplasy.pdf (Accessed on December 01, 2020).
  7. Nicolle LE, Gupta K, Bradley SF, et al. Clinical Practice Guideline for the Management of Asymptomatic Bacteriuria: 2019 Update by the Infectious Diseases Society of America. Clin Infect Dis 2019; 68:e83.
  8. Lamb MJ, Baillie L, Pajak D, et al. Elimination of Screening Urine Cultures Prior to Elective Joint Arthroplasty. Clin Infect Dis 2017; 64:806.
  9. Bailin S, Noiseux N, Pottinger JM, et al. Screening Patients Undergoing Total Hip or Knee Arthroplasty with Perioperative Urinalysis and the Effect of a Practice Change on Antimicrobial Use. Infect Control Hosp Epidemiol 2017; 38:281.
  10. Sousa R, Muñoz-Mahamud E, Quayle J, et al. Is asymptomatic bacteriuria a risk factor for prosthetic joint infection? Clin Infect Dis 2014; 59:41.
  11. Kapadia BH, Berg RA, Daley JA, et al. Periprosthetic joint infection. Lancet 2016; 387:386.
  12. Pieringer H, Stuby U, Biesenbach G. Patients with rheumatoid arthritis undergoing surgery: how should we deal with antirheumatic treatment? Semin Arthritis Rheum 2007; 36:278.
  13. AlBuhairan B, Hind D, Hutchinson A. Antibiotic prophylaxis for wound infections in total joint arthroplasty: a systematic review. J Bone Joint Surg Br 2008; 90:915.
  14. Wyles CC, Hevesi M, Osmon DR, et al. 2019 John Charnley Award: Increased risk of prosthetic joint infection following primary total knee and hip arthroplasty with the use of alternative antibiotics to cefazolin: the value of allergy testing for antibiotic prophylaxis. Bone Joint J 2019; 101-B:9.
  15. Wu VJ, Iloanya MC, Sanchez FL, et al. Is Patient-reported Penicillin Allergy Independently Associated with Increased Risk of Prosthetic Joint Infection After Total Joint Arthroplasty of the Hip, Knee, and Shoulder? Clin Orthop Relat Res 2020; 478:2699.
  16. Pagani NR, Moverman MA, Puzzitiello RN, et al. Preoperative Allergy Testing for Patients Reporting Penicillin and Cephalosporin Allergies is Cost-Effective in Preventing Infection after Total Knee and Hip Arthroplasty. J Arthroplasty 2021; 36:700.
  17. Marigi EM, Bartels DW, Yoon JH, et al. Antibiotic Prophylaxis with Cefazolin Is Associated with Lower Shoulder Periprosthetic Joint Infection Rates Than Non-Cefazolin Alternatives. J Bone Joint Surg Am 2022; 104:872.
  18. Southwell-Keely JP, Russo RR, March L, et al. Antibiotic prophylaxis in hip fracture surgery: a metaanalysis. Clin Orthop Relat Res 2004; :179.
  19. Boxma H, Broekhuizen T, Patka P, Oosting H. Randomised controlled trial of single-dose antibiotic prophylaxis in surgical treatment of closed fractures: the Dutch Trauma Trial. Lancet 1996; 347:1133.
  20. Trampuz A, Zimmerli W. Antimicrobial agents in orthopaedic surgery: Prophylaxis and treatment. Drugs 2006; 66:1089.
  21. Soriano A, Bori G, García-Ramiro S, et al. Timing of antibiotic prophylaxis for primary total knee arthroplasty performed during ischemia. Clin Infect Dis 2008; 46:1009.
  22. The diagnosis of periprosthetic joint infections of the hip and knee. Guidelines and evidence report. Adopted by the American Academy of Orthopaedic Surgeons Board of Directors, June 18, 2010.
  23. Wouthuyzen-Bakker M, Benito N, Soriano A. The Effect of Preoperative Antimicrobial Prophylaxis on Intraoperative Culture Results in Patients with a Suspected or Confirmed Prosthetic Joint Infection: a Systematic Review. J Clin Microbiol 2017; 55:2765.
  24. Gillespie WJ. Prevention and management of infection after total joint replacement. Clin Infect Dis 1997; 25:1310.
  25. Nelson CL, Green TG, Porter RA, Warren RD. One day versus seven days of preventive antibiotic therapy in orthopedic surgery. Clin Orthop Relat Res 1983; :258.
  26. Siddiqi A, Forte SA, Docter S, et al. Perioperative Antibiotic Prophylaxis in Total Joint Arthroplasty: A Systematic Review and Meta-Analysis. J Bone Joint Surg Am 2019; 101:828.
  27. Parvizi J, Saleh KJ, Ragland PS, et al. Efficacy of antibiotic-impregnated cement in total hip replacement. Acta Orthop 2008; 79:335.
  28. Bourne RB. Prophylactic use of antibiotic bone cement: an emerging standard--in the affirmative. J Arthroplasty 2004; 19:69.
  29. Fish DN, Hoffman HM, Danziger LH. Antibiotic-impregnated cement use in U.S. hospitals. Am J Hosp Pharm 1992; 49:2469.
  30. Engesaeter LB, Lie SA, Espehaug B, et al. Antibiotic prophylaxis in total hip arthroplasty: effects of antibiotic prophylaxis systemically and in bone cement on the revision rate of 22,170 primary hip replacements followed 0-14 years in the Norwegian Arthroplasty Register. Acta Orthop Scand 2003; 74:644.
  31. van Kasteren ME, Manniën J, Ott A, et al. Antibiotic prophylaxis and the risk of surgical site infections following total hip arthroplasty: timely administration is the most important factor. Clin Infect Dis 2007; 44:921.
  32. Jiranek W. Antibiotic-loaded cement in total hip replacement: current indications, efficacy, and complications. Orthopedics 2005; 28:s873.
  33. Hanssen AD. Prophylactic use of antibiotic bone cement: an emerging standard--in opposition. J Arthroplasty 2004; 19:73.
  34. Block JE, Stubbs HA. Reducing the risk of deep wound infection in primary joint arthroplasty with antibiotic bone cement. Orthopedics 2005; 28:1334.
  35. Cummins JS, Tomek IM, Kantor SR, et al. Cost-effectiveness of antibiotic-impregnated bone cement used in primary total hip arthroplasty. J Bone Joint Surg Am 2009; 91:634.
  36. Roberts DW. What is the role of antibiotic-containing cement in total knee arthroplasty? J Bone Joint Surg Am 2013; 95:e62.
  37. Westberg M, Frihagen F, Brun OC, et al. Effectiveness of gentamicin-containing collagen sponges for prevention of surgical site infection after hip arthroplasty: a multicenter randomized trial. Clin Infect Dis 2015; 60:1752.
  38. Watters W 3rd, Rethman MP, Hanson NB, et al. Prevention of Orthopaedic Implant Infection in Patients Undergoing Dental Procedures. J Am Acad Orthop Surg 2013; 21:180.
  39. Sollecito TP, Abt E, Lockhart PB, et al. The use of prophylactic antibiotics prior to dental procedures in patients with prosthetic joints: Evidence-based clinical practice guideline for dental practitioners--a report of the American Dental Association Council on Scientific Affairs. J Am Dent Assoc 2015; 146:11.
  40. Wahl MJ. Myths of dental-induced prosthetic joint infections. Clin Infect Dis 1995; 20:1420.
  41. Berbari EF, Osmon DR, Carr A, et al. Dental procedures as risk factors for prosthetic hip or knee infection: a hospital-based prospective case-control study. Clin Infect Dis 2010; 50:8.
  42. Young H, Hirsh J, Hammerberg EM, Price CS. Dental disease and periprosthetic joint infection. J Bone Joint Surg Am 2014; 96:162.
  43. Skaar DD, O'Connor H, Hodges JS, Michalowicz BS. Dental procedures and subsequent prosthetic joint infections: findings from the Medicare Current Beneficiary Survey. J Am Dent Assoc 2011; 142:1343.
  44. Eskinazi D, Rathbun W. Is systematic antimicrobial prophylaxis justified in dental patients with prosthetic joints? Oral Surg Oral Med Oral Pathol 1988; 66:430.
  45. Simmons NA, Ball AP, Cawson RA, et al. Case against antibiotic prophylaxis for dental treatment of patients with joint prostheses. Lancet 1992; 339:301.
  46. Thornhill MH, Crum A, Rex S, et al. Analysis of Prosthetic Joint Infections Following Invasive Dental Procedures in England. JAMA Netw Open 2022; 5:e2142987.
  47. American Dental Association. MouthHealthy. https://www.mouthhealthy.org/en (Accessed on January 27, 2022).
  48. Gupta A, Osmon DR, Hanssen AD, et al. Genitourinary Procedures as Risk Factors for Prosthetic Hip or Knee Infection: A Hospital-Based Prospective Case-Control Study. Open Forum Infect Dis 2015; 2:ofv097.
  49. American Urological Association, American Academy of Orthopaedic Surgeons. Antibiotic prophylaxis for urological patients with total joint replacements. J Urol 2003; 169:1796.
  50. ASGE STANDARDS OF PRACTICE COMMITTEE, Banerjee S, Shen B, et al. Antibiotic prophylaxis for GI endoscopy. Gastrointest Endosc 2008; 67:791.
Topic 7667 Version 53.0

References